<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03265353</url>
  </required_header>
  <id_info>
    <org_study_id>487998-8</org_study_id>
    <nct_id>NCT03265353</nct_id>
  </id_info>
  <brief_title>Vascular Effects of Dietary Potassium</brief_title>
  <official_title>Vascular Effects of Dietary Potassium in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if dietary potassium can attenuate the deleterious&#xD;
      effects of high sodium on blood vessel function in healthy, salt-resistant participants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease remains a major Public Health problem in the U.S. and is the result of&#xD;
      diseases such as atherosclerosis and high blood pressure (BP). Several dietary factors have&#xD;
      been implicated as risk factors including high sodium and low potassium diets. Indeed, it is&#xD;
      well known that excess sodium can increase BP while potassium rich diets have BP lowering&#xD;
      properties. While the role of these two nutrients on BP is widely accepted, their impact on&#xD;
      the vasculature has received less attention. Endothelial dysfunction, characterized by&#xD;
      impaired dilation is an important non-traditional risk factor for atherosclerosis. Data in&#xD;
      animal models suggest that salt loading, independent of changes in BP, results in endothelial&#xD;
      dysfunction while evidence is mounting that potassium may be beneficial to vascular health.&#xD;
      Further, potassium may be more effective in the presence of high sodium however the role of&#xD;
      potassium in protecting the vasculature from a high sodium diet in salt-resistant adults has&#xD;
      not been explored. A potential mechanism responsible for sodium induced vascular dysfunction&#xD;
      is overproduction of reactive oxygen species resulting in reduced nitric oxide (NO)&#xD;
      production/ bioavailability. It has been suggested that potassium can counteract sodium's&#xD;
      effect by reducing ROS. The central hypothesis is that potassium can protect against the&#xD;
      deleterious effects of high sodium on the vasculature by reducing oxidative stress and&#xD;
      preserving NO. In this grant, the investigators propose to use a 21-day controlled feeding&#xD;
      study to compare the effects of a high sodium diet (300 mmol) combined with either a high&#xD;
      (120 mmol) or moderate (65 mmol) amount of potassium and low sodium (50 mmol) combined with&#xD;
      moderate potassium (crossover design, diet order sequence randomized) on 2 levels of the&#xD;
      vasculature, conduit artery and microvasculature. These experiments will be performed in&#xD;
      salt-resistant participants to study the vascular effects alone, independent of changes in&#xD;
      BP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2013</start_date>
  <completion_date type="Actual">September 22, 2019</completion_date>
  <primary_completion_date type="Actual">September 22, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants will complete each arm. It is a crossover, randomized design.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Conduit artery endothelial-dependent dilation</measure>
    <time_frame>on the 7th day of each diet</time_frame>
    <description>The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD</description>
  </primary_outcome>
  <other_outcome>
    <measure>Arterial Stiffness</measure>
    <time_frame>on 7th day of each diet</time_frame>
    <description>Assessed by carotid to femoral artery pulse wave velocity</description>
  </other_outcome>
  <other_outcome>
    <measure>Wave reflection</measure>
    <time_frame>on 7th day of each diet</time_frame>
    <description>Assessed by augmentation index</description>
  </other_outcome>
  <other_outcome>
    <measure>Endothelial cell expression of oxidative stress marker</measure>
    <time_frame>on the 7th day of each diet</time_frame>
    <description>Assessed in venous endothelial cells from participants.</description>
  </other_outcome>
  <other_outcome>
    <measure>Ambulatory blood pressure</measure>
    <time_frame>7 days</time_frame>
    <description>Assessed by 24 hr ambulatory blood pressure monitoring.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>Moderate Potassium/Low Sodium Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/low sodium diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Potassium/High Sodium Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the moderate potassium/high sodium diet.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Potassium/High Sodium Diet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Vascular function will be assessed at both the conduit artery and microvascular level after 7 days of the high potassium/high sodium diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate Potassium/Low Sodium Diet</intervention_name>
    <description>7 days of the prescribed diet</description>
    <arm_group_label>Moderate Potassium/Low Sodium Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate Potassium/High Sodium Diet</intervention_name>
    <description>7 days of the prescribed diet</description>
    <arm_group_label>Moderate Potassium/High Sodium Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Potassium/High Sodium Diet</intervention_name>
    <description>7 days of the prescribed diet</description>
    <arm_group_label>High Potassium/High Sodium Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  normal blood pressure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hypertension&#xD;
&#xD;
          -  history of heart disease&#xD;
&#xD;
          -  diabetes&#xD;
&#xD;
          -  kidney disease&#xD;
&#xD;
          -  obese (BMI â‰¥30)&#xD;
&#xD;
          -  significant weight changes in the last 6 months&#xD;
&#xD;
          -  use of tobacco products&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  on a special diet (gluten free; vegan)&#xD;
&#xD;
          -  take any medications for the above conditions&#xD;
&#xD;
          -  endurance trained athletes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon L Lennon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19716</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 25, 2017</study_first_submitted>
  <study_first_submitted_qc>August 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2017</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Potassium</keyword>
  <keyword>Sodium</keyword>
  <keyword>Vascular function</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

